A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AGEs / advanced glycation end products

[Related PubMed/MEDLINE]
Total Number of Papers: 4783
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AGEs  (>> Co-occurring Abbreviation)
Long Form:   advanced glycation end products
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 2'-Deoxyribose mediated glycation leads to alterations in BSA structure via generation of carbonyl species. BSA, RCS
2020 2,5-diketopiperazines mitigate the amount of advanced glycation end products accumulated with age in human dermal fibroblasts. DKPs
2020 A Bibenzyl Component Moscatilin Mitigates Glycation-Mediated Damages in an SH-SY5Y Cell Model of Neurodegenerative Diseases through AMPK Activation and RAGE/NF-kappaB Pathway Suppression. AMPK
2020 A biochemical & biophysical study on in-vitro anti-glycating potential of iridin against d-Ribose modified BSA. ANS, BSA, CC, CR, EGPs, Gly-BSA, HMF, ID, ThT
2020 A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNalpha + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress. CHC, GT, HCV, IFN-alpha, IR, OS, SOD
2020 A New Italian Purple Corn Variety (Moradyn) Byproduct Extract: Antiglycative and Hypoglycemic In Vitro Activities and Preliminary Bioaccessibility Studies. ---
2020 A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort). AU, CI, PA, SAF, SQUASH
2020 A unifying model of glucotoxicity in human renal proximal tubular epithelial cells and the effect of the SGLT2 inhibitor dapagliflozin. GAPDH, IL-8, O-GlcNAc, PKC, ROS, RPTECs, SGLT2, TGF-beta1
2020 Accelerated Kidney Aging in Diabetes Mellitus. DM, DN
10  2020 Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes. HFD-induced, RAGE, T2D
11  2020 Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. AS, AVA, DM, IL-6, RAGE, ROS, sRAGE
12  2020 Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study. ---
13  2020 Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study. ---
14  2020 Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes. ECM, OA
15  2020 Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria. DN, EMT, RAGE
16  2020 Advanced Glycation End Product Accumulation in Subjects with Open-Angle Glaucoma with and without Exfoliation. EG, PG, SAF
17  2020 Advanced Glycation End Product Accumulation is Associated with Lower Cognitive Performance in an Older General Population: The Nagahama Study. ---
18  2020 Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort. CERAD, ELISA
19  2020 Advanced Glycation End Product Inhibition by Alkaloids from Ocotea paranapiacabensis for the Prevention of Skin Aging. ADME
20  2020 Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactions. HMGB1, LPS, TNF
21  2020 Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. ---
22  2020 Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation. ALL, CV, GVHD, HSCT, TBI
23  2020 Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease. NDD, PC, PD
24  2020 Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells. HCE, NF, RAGE
25  2020 Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis. alpha-SMA, PD
26  2020 Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study. CRP, HDL, MetS, NAFLD
27  2020 Advanced Glycation End Products Enhance Biofilm Formation by Promoting Extracellular DNA Release Through sigB Upregulation in Staphylococcus aureus. DFI, DFU, eDNA
28  2020 Advanced glycation end products enhance M1 macrophage polarization by activating the MAPK pathway. GSIS, T2DM
29  2020 Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1alpha/PDK4 pathway. BSA, HIF-1alpha, PDK4
30  2020 Advanced glycation end products facilitate the proliferation and reduce early apoptosis of cardiac microvascular endothelial cells via PKCbeta signaling pathway: Insight from diabetic cardiomyopathy. CCK-8, CMECs, FITC, p-ERK, PI, PKC, PMA, RAGE
31  2020 Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review. ---
32  2020 Advanced glycation end products in diabetes, cancer and phytochemical therapy. MG, NF, PI3K, RAGE
33  2020 Advanced glycation end products in musculoskeletal system and disorders. RAGE
34  2020 Advanced glycation end products increased placental vascular permeability of human BeWo cells via RAGE/NF-kB signaling pathway. TEER
35  2020 Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models. AGE, PDR, RAGE, ROCK
36  2020 Advanced Glycation End Products Induce Proliferation and Migration of Human Aortic Smooth Muscle Cells through PI3K/AKT Pathway. F-actin, HASMCs, RAGE, VSMCs
37  2020 Advanced glycation end products induce proliferation, invasion and epithelial-mesenchymal transition of human SW480 colon cancer cells through the PI3K/AKT signaling pathway. E-cadherin, EMT
38  2020 Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State. ACTA2, CML, ELISA
39  2020 Advanced glycation end products inhibit neural stem cell differentiation via upregualtion of HDAC3 expression. DACD, DM, NSCs
40  2020 Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells by modulating Wnt/beta-catenin signalling pathway via DNA methylation. 5-aza-dC, ASCs
41  2020 Advanced glycation end products reduce macrophage-mediated killing of Staphylococcus aureus by ARL8 upregulation and inhibition of autolysosome formation. ---
42  2020 Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease. ---
43  2020 Advanced glycation end-products (AGE) trapping agents: Design and synthesis of nature inspired indeno[2,1-c]pyridinones. AGE
44  2020 Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes. AOPP, FRAP
45  2020 Advanced glycation end-products disrupt brain microvascular endothelial cell barrier: The role of mitochondria and oxidative stress. BBB, BSA, BSA
46  2020 Advanced glycation end-products increase lipocalin 2 expression in human oral epithelial cells. dHL-60, DM, IL-6, LCN2, PgLPS
47  2020 Advanced glycation end-products suppress autophagy by AMPK/mTOR signaling pathway to promote vascular calcification. BSA, TEM, VSMC
48  2020 Advanced glycosylation end products (AGEs) controls proliferation, invasion and permeability through orchestrating ARHGAP18/RhoA pathway in human umbilical vein endothelial cells. CCK-8, HUVECs
49  2020 Age-dependent altered redox homeostasis in the chronodisrupted rat model and moderation by melatonin administration. AChE, ALAN, AOPP, CD, FRAP, MDA, MLT, PCO, PMRS, ROS, SA
50  2020 AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3. DKD, DM, EZH2
51  2020 AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment. CLLI
52  2020 AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment. AF
53  2020 AGE-RAGEsynergy influences programmed cell death signaling to promote cancer. ---
54  2020 Age-related shifts in gut microbiota contribute to cognitive decline in aged rats. BDNF, FMT, RAGE
55  2020 AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy. ER, ncRNAs, RAGE, ROS
56  2020 AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes. NASH
57  2020 AGEs-RAGE axis causes endothelial-to-mesenchymal transition in early calcific aortic valve disease via TGF-beta1 and BMPR2 signaling. ALP, alpha-SMA, CAVD, EndMT, TGF-beta1, VE-cadherin
58  2020 Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-kappaB signaling pathways in C57BL/6 mice. BUN, CAT, Cr, DN, FBG, HDL-C, HFD, INS, LDL-C, MDA, SOD, STZ, T2D, TC, TG
59  2020 Allithiamine Alleviates Hyperglycaemia-Induced Endothelial Dysfunction. HUVECs
60  2020 alpha-Bisabolol suppresses the inflammatory response and ECM catabolism in advanced glycation end products-treated chondrocytes and attenuates murine osteoarthritis. BISA, DMM, ECM, JNK, NF-kappaB, OA
61  2020 Altered Mineral Metabolism and Disequilibrium Between Calcification Promoters and Inhibitors in Chronic Hemodialysis Patients. CRP, FGF23, HD, MDA, MGP, Se, Zn
62  2020 Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies. DM, HAP1
63  2020 An Electrochemical Chip to Monitor In Vitro Glycation of Proteins and Screening of Antiglycation Potential of Drugs. ---
64  2020 An invitro approach to unveil the structural alterations in d-ribose induced glycated fibrinogen. NEPTM
65  2020 An update on the potential role of advanced glycation end products in glycolipid metabolism. ---
66  2020 Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS. CHOP, ER, GLCs, PCOS, RAGE, TUDCA
67  2020 Antagonism of GPR4 with NE 52-QQ57 and the Suppression of AGE-Induced Degradation of Type II Collagen in Human Chondrocytes. COX2, IL, iNOS, MMP, NF-kappaB, NO, OA, PGE2, TNF-alpha
68  2020 Anti-glycation effect and the alpha-amylase, lipase, and alpha-glycosidase inhibition properties of a polyphenolic fraction derived from citrus wastes. ---
69  2020 Anti-Opioid Antibodies in Individuals Using Chronic Opioid Therapy for Lower Back Pain. ELISA, OUD
70  2020 Antiglycation Activities and Common Mechanisms Mediating Vasculoprotective Effect of Quercetin and Chrysin in Metabolic Syndrome. CH, DPPH, MetS, MG
71  2020 Antioxidant and Antiglycation Activities of Syzygium paniculatum Gaertn and Inhibition of Digestive Enzymes Relevant to Type 2 Diabetes Mellitus. ---
72  2020 Antioxidative and Angiogenesis-Promoting Effects of Tetrahedral Framework Nucleic Acids in Diabetic Wound Healing with Activation of the Akt/Nrf2/HO-1 Pathway. HO-1, HUVECs, NO, Nrf2, ROS, tFNAs, VEGF-A
73  2020 Antirhea borbonica Aqueous Extract Protects Albumin and Erythrocytes from Glycoxidative Damages. Ab, MGO
74  2020 APOE epsilon4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism. G82S, sRAGE
75  2020 Application of a Pseudotargeted MS Method for the Quantification of Glycated Hemoglobin for the Improved Diagnosis of Diabetes Mellitus. DDA, iRT, PRM, T2DM
76  2020 Are Finger Skin Fluorophores Other Than Advanced Glycation End Products (AGEs) Associated With Impaired Musculoskeletal Properties? ---
77  2020 Assessment of advanced glycation end products in the peri-implant sulcular fluid among moderate cigarette-smokers and nonsmokers with peri-implantitis. CBL, GI, PD, PI, PISF
78  2020 Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study. HR
79  2020 Association between the tissue accumulation of advanced glycation end products and exercise capacity in cardiac rehabilitation patients. CR, CVD, DM, SAF
80  2020 Association of physical fitness with skin autofluorescence-derived advanced glycation end products in children. BMI, BP, CRF
81  2020 Awakening cortisol indicators, advanced glycation end products, stress perception, depression and anxiety in parents of children with chronic conditions. ASD, CG, CP, DMT1, DS
82  2020 Beneficial Effect of Mildly Pasteurized Whey Protein on Intestinal Integrity and Innate Defense in Preterm and Near-Term Piglets. EH-WPC, IMF, MP-WPC
83  2020 Beta carotene protects H9c2 cardiomyocytes from advanced glycation end product-induced endoplasmic reticulum stress, apoptosis, and autophagy via the PI3K/Akt/mTOR signaling pathway. ATF4, Bax, BC, Bcl-2, CHOP, cTnI, DCM, ELISA, ER, GRP78, GSH-Px, LC3, LDH, MDA, p-AKT, p-mTOR, p-PI3K, ROS, SOD
84  2020 Binding of CML-Modified as Well as Heat-Glycated beta-lactoglobulin to Receptors for AGEs Is Determined by Charge and Hydrophobicity. CML
85  2020 Bombax ceiba (Linn.) calyxes ameliorate methylglyoxal-induced oxidative stress via modulation of RAGE expression: identification of active phytometabolites by GC-MS analysis. BCCE, GC-MS, GLO1, MG, NOX, ROS
86  2020 Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency. AOPPs, C1-INH, HAE, PBMCs, ROS
87  2020 Can advanced glycation end-products and their receptors be affected by weight loss? A systematic review. esRAGE, sRAGE
88  2020 Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? CRSwNP, EMT, ERK, MAPKs, NP, RAGE
89  2020 Casein Hydrolysate Containing Milk-Derived Peptides Reduces Facial Pigmentation Partly by Decreasing Advanced Glycation End Products in the Skin: A Randomized Double-Blind Placebo-Controlled Trial. baPWV
90  2020 Cellular and Molecular Aspects of Blood Cell-Endothelium Interactions in Vascular Disorders. GP, ICAM, PV, RBCs, RVO, VCAM
91  2020 Characterization of the acidic species of a monoclonal antibody using free flow electrophoresis fractionation and mass spectrometry. FFE, icIEF
92  2020 Chemical screening identifies an extract from marine Pseudomonas sp.-PTR-08 as an anti-aging agent that promotes fission yeast longevity by modulating the Pap1-ctt1+ pathway and the cell cycle. ROS
93  2020 Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis. BSA, CABG, CAD
94  2020 Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes. BMI, GLP-1, i.v, OGTT, sRAGE
95  2020 Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study. CHD, CTCA, RAGE
96  2020 Comparative study of different glycating agents on human plasma and vascular cells. ---
97  2020 Comparison Between Biomarkers of Kidney Injury, Inflammation, and Oxidative Stress in Patients with Diabetic Nephropathy and Type 2 Diabetes Mellitus. DN, MMP-2, T2DM, TNF-alpha
98  2020 Comparison between Standard Single Chamber vs Dual Chamber Low Glucose Degradation Product Peritoneal Dialysis Fluids. DC, ECW/TBW, GDPs, PD, SAF
99  2020 Comparison of glucose degradation product and receptor levels in dabetic and normal pregnancy. BMI, CML
100  2020 Comparison of skin autofluorescence, a marker of tissue advanced glycation end-products in the fistula and non-fistula arms of patients treated by hemodialysis. AVF, HD, SAF